HIV in the United States by Race and Ethnicity: PrEP Coverage
PrEP (pre-exposure prophylaxis) coverage is one of the six Ending the HIV Epidemic in the U.S. indicators. PrEP coverage is the estimated percentage of people with indications for PrEP classified as having been prescribed PrEP.
*PrEP coverage is the estimated percentage of people with indications for PrEP classified as having been prescribed PrEP.
† Among people aged 16 and older.
‡ Race and ethnicity data are available for less than 40% of people prescribed PrEP. For more information, visit the Surveillance Report Technical Notes
** Black refers to people having origins in any of the Black racial groups of Africa. African American is a term often used for people of African descent with ancestry in North America.
†† Hispanic/Latino people can be of any race.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2021. HIV Surveillance Supplemental Report 2023;28(4).
- CDC. Diagnoses of HIV infection in the United States and dependent areas, 2021. HIV Surveillance Report 2023;34.
- CDC. Estimated HIV incidence and prevalence in the United States 2017–2021. HIV Surveillance Supplemental Report 2023;28(3).
- CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2021. HIV Surveillance Supplemental Report 2023;28(4).
- CDC. HIV infection risk, prevention, and testing behaviors among persons who inject drugs—National HIV Behavioral Surveillance: injection drug use, 23 U.S. Cities, 2018 [PDF – 2 MB]. HIV Surveillance Special Report 2020;24.
- CDC. Sexually transmitted disease surveillance, 2021. Accessed April 26, 2023.
- CDC. Quality of life and HIV stigma—Indicators for the National HIV/AIDS Strategy, 2022–2025, CDC Medical Monitoring Project, 2017–2020 cycles. HIV Surveillance Special Report 2022;30.
- CDC. Behavioral and clinical characteristics of persons with diagnosed HIV infection—Medical Monitoring Project, United States 2020 cycle (June 2020–May 2021). HIV Surveillance Special Report 2022;29.
